RxDoctor Payments Data

Kaitlin Weeks, PA

Physician Assistant · Ocoee, TNNPI 1720568462

Payments from drug & device makers

$566in general payments, 2019–2025

Across 32 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$293
  • AstraZeneca$63
  • Lilly USA, LLC$48
  • Amarin Pharma, Inc.$42
  • Pfizer$37
  • Biohaven Pharmaceutical Holding Company Ltd.$19
  • plus $64 from 4 others

What the payments were for

  • Food & beverage$566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$566 in reported general payments places this provider in the 60th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$3,533
Medicare patients
53
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$72,409
RybelsusSemaglutide19$36,352
EliquisApixaban32$35,110
FarxigaDapagliflozin Propanediol30$29,541
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$20,749
JardianceEmpagliflozin24$16,770
JanuviaSitagliptin Phosphate14$14,590
TrulicityDulaglutide14$13,683
MounjaroTirzepatide11$11,827
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm47$7,020
Combivent RespimatIpratropium/Albuterol Sulfate12$5,894
Spiriva HandihalerTiotropium Bromide12$5,794
Albuterol Sulfate HfaAlbuterol Sulfate111$2,266
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,238
Atorvastatin Calcium210$2,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$293$108,76186 claims
AstraZenecaFarxiga, Breztri Aerosphere$63$50,29163 claims
PfizerEliquis$37$35,11032 claims
Lilly USA, LLCTrulicity, Mounjaro$48$25,51025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Ocoee

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →